Janssen’s HIV treatment, ‘Presecobics’ applied by health insurance from March
Janssen Korea(CEO Ok-yeon Kim) announced ‘Presecobics(generic name: darunavir 800mg, cobicistat 150mg),’ a complex human immunodeficiency virus(HIV) treatment, will be applied by the National Health Insurance from the 1st of March as a combination therapy of adult HIV patients under the Ministry ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
